Literature DB >> 30947198

Benign Paroxysmal Positional Vertigo.

Ryan S Instrum, Lorne S Parnes.   

Abstract

Purpose of Chapter: This chapter discusses the recent progress made in understanding the pathophysiology, diagnosis, and treatment of benign paroxysmal positional vertigo (BPPV). Recent Findings: Recent evidence supports the canalolithiasis model as the pathophysiological mechanism and predominant subtype of BPPV. Scanning electron micrographs of extracted posterior semicircular canal contents show free-floating otoconia of utricular origin. Calcium homeostasis has also been shown to contribute to the pathogenesis of the disorder by creating an environment in which otoconia are more prone to dislodging from their native gelatinous substrate. Recent findings have served to identify variant-specific provocative tests with the greatest diagnostic utility while simultaneously maximizing their diagnostic yield. Current data have also helped elucidate the efficacy of repositioning maneuvers and surgical interventions. Summary: BPPV is a disease of altered endolymph and cupular mechanics secondary to dislodged otoconia. It is amenable to particle repositioning maneuvers in most instances or surgical occlusion for intractable cases.
© 2019 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2019        PMID: 30947198     DOI: 10.1159/000490273

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  6 in total

1.  Optimizing Testing for BPPV - The Loaded Dix-Hallpike.

Authors:  Luke Andera; William James Azeredo; Joseph Scott Greene; Haiyan Sun; Jeffrey Walter
Journal:  J Int Adv Otol       Date:  2020-08       Impact factor: 1.017

2.  Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.

Authors:  Hong-Bin Cai; Lei Duan; Ting Tian; Zi-Chao Li; Chong-Chong Zhao; Zhao-Ming Ge
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

3.  Epley manoeuvre for posterior semicircular canal benign paroxysmal positional vertigo in people with multiple sclerosis: protocol of a randomised controlled trial.

Authors:  Cristina García-Muñoz; María-Dolores Cortés-Vega; Juan Carlos Hernández-Rodríguez; Rocio Palomo-Carrión; Rocío Martín-Valero; María Jesús Casuso-Holgado
Journal:  BMJ Open       Date:  2021-03-18       Impact factor: 2.692

4.  Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway.

Authors:  Jing Hui; Qi Lei; Zhi Ji; Dingjing Zi
Journal:  Biol Res       Date:  2022-04-04       Impact factor: 5.612

5.  Relationship between benign paroxysmal positional vertigo (BPPV) and sleep quality.

Authors:  Khosrow Iranfar; Samaeh Azad
Journal:  Heliyon       Date:  2022-01-06

6.  Repositioning Chairs in the Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo - A Systematic Review.

Authors:  Serkan Abdulovski; Mads Klokker
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.